Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-05 7:29:57 pm | Rigel Pharmaceuticals, Inc. (RIGL) Q4 2023 Earnings Call Transcript | SeekingAlpha |
| 2024-03-05 2:10:5 pm | Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4 | Zacks |
| 2024-03-05 1:1:0 pm | Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | PR Newswire |
| 2024-02-28 5:27:0 am | OmniAb, Inc. (OABI) Soars 10.5%: Is Further Upside Left in the Stock? | Zacks |
| 2024-02-27 5:5:0 am | Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update | PR Newswire |
| 2024-02-22 4:50:0 am | Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO® | PR Newswire |
| 2024-02-19 5:34:0 am | Can Rigel Pharmaceuticals (RIGL) Beat Q4 Earnings Estimates? | Zacks |
| 2024-01-15 6:13:40 am | When Will Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Become Profitable? | Simply Wall St. |
| 2024-01-08 5:5:0 am | Rigel Pharmaceuticals Provides Business Update | PR Newswire |
Please consider a small donation if you think this website provides you with relevant information